deferasirox has been researched along with Peptic Ulcer Perforation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Javed, A; Maryam, N; Shah, MZ; Shakir, FTZ; Siddiqui, R; Sultan, R | 1 |
1 other study(ies) available for deferasirox and Peptic Ulcer Perforation
| Article | Year |
|---|---|
Drug-induced duodenal perforation in the paediatric patient with thalassemia major, an unreported side effect of iron- chelating agent: A case report.
Topics: beta-Thalassemia; Chelating Agents; Child; Deferasirox; Duodenal Ulcer; Female; Humans; Iron; Peptic Ulcer Perforation | 2022 |